Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation

Oncogenic Ras mutations are common drivers in myeloid leukemia. Here, the authors show in patient cells and in mice that oncogenic K-Ras activates NLRP3 inflammasome to drive myeloproliferation, which can be reversed by genetic or pharmacologic NLRP3 blockade.

Guardado en:
Detalles Bibliográficos
Autores principales: Shaima’a Hamarsheh, Lena Osswald, Benedikt S. Saller, Susanne Unger, Donatella De Feo, Janaki Manoja Vinnakota, Martina Konantz, Franziska M. Uhl, Heiko Becker, Michael Lübbert, Khalid Shoumariyeh, Christoph Schürch, Geoffroy Andrieux, Nils Venhoff, Annette Schmitt-Graeff, Sandra Duquesne, Dietmar Pfeifer, Matthew A. Cooper, Claudia Lengerke, Melanie Boerries, Justus Duyster, Charlotte M. Niemeyer, Miriam Erlacher, Bruce R. Blazar, Burkard Becher, Olaf Groß, Tilman Brummer, Robert Zeiser
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
Q
Acceso en línea:https://doaj.org/article/8d60e15645a540748f0978aece6a6bc5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8d60e15645a540748f0978aece6a6bc5
record_format dspace
spelling oai:doaj.org-article:8d60e15645a540748f0978aece6a6bc52021-12-02T15:37:15ZOncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation10.1038/s41467-020-15497-12041-1723https://doaj.org/article/8d60e15645a540748f0978aece6a6bc52020-04-01T00:00:00Zhttps://doi.org/10.1038/s41467-020-15497-1https://doaj.org/toc/2041-1723Oncogenic Ras mutations are common drivers in myeloid leukemia. Here, the authors show in patient cells and in mice that oncogenic K-Ras activates NLRP3 inflammasome to drive myeloproliferation, which can be reversed by genetic or pharmacologic NLRP3 blockade.Shaima’a HamarshehLena OsswaldBenedikt S. SallerSusanne UngerDonatella De FeoJanaki Manoja VinnakotaMartina KonantzFranziska M. UhlHeiko BeckerMichael LübbertKhalid ShoumariyehChristoph SchürchGeoffroy AndrieuxNils VenhoffAnnette Schmitt-GraeffSandra DuquesneDietmar PfeiferMatthew A. CooperClaudia LengerkeMelanie BoerriesJustus DuysterCharlotte M. NiemeyerMiriam ErlacherBruce R. BlazarBurkard BecherOlaf GroßTilman BrummerRobert ZeiserNature PortfolioarticleScienceQENNature Communications, Vol 11, Iss 1, Pp 1-17 (2020)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Shaima’a Hamarsheh
Lena Osswald
Benedikt S. Saller
Susanne Unger
Donatella De Feo
Janaki Manoja Vinnakota
Martina Konantz
Franziska M. Uhl
Heiko Becker
Michael Lübbert
Khalid Shoumariyeh
Christoph Schürch
Geoffroy Andrieux
Nils Venhoff
Annette Schmitt-Graeff
Sandra Duquesne
Dietmar Pfeifer
Matthew A. Cooper
Claudia Lengerke
Melanie Boerries
Justus Duyster
Charlotte M. Niemeyer
Miriam Erlacher
Bruce R. Blazar
Burkard Becher
Olaf Groß
Tilman Brummer
Robert Zeiser
Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation
description Oncogenic Ras mutations are common drivers in myeloid leukemia. Here, the authors show in patient cells and in mice that oncogenic K-Ras activates NLRP3 inflammasome to drive myeloproliferation, which can be reversed by genetic or pharmacologic NLRP3 blockade.
format article
author Shaima’a Hamarsheh
Lena Osswald
Benedikt S. Saller
Susanne Unger
Donatella De Feo
Janaki Manoja Vinnakota
Martina Konantz
Franziska M. Uhl
Heiko Becker
Michael Lübbert
Khalid Shoumariyeh
Christoph Schürch
Geoffroy Andrieux
Nils Venhoff
Annette Schmitt-Graeff
Sandra Duquesne
Dietmar Pfeifer
Matthew A. Cooper
Claudia Lengerke
Melanie Boerries
Justus Duyster
Charlotte M. Niemeyer
Miriam Erlacher
Bruce R. Blazar
Burkard Becher
Olaf Groß
Tilman Brummer
Robert Zeiser
author_facet Shaima’a Hamarsheh
Lena Osswald
Benedikt S. Saller
Susanne Unger
Donatella De Feo
Janaki Manoja Vinnakota
Martina Konantz
Franziska M. Uhl
Heiko Becker
Michael Lübbert
Khalid Shoumariyeh
Christoph Schürch
Geoffroy Andrieux
Nils Venhoff
Annette Schmitt-Graeff
Sandra Duquesne
Dietmar Pfeifer
Matthew A. Cooper
Claudia Lengerke
Melanie Boerries
Justus Duyster
Charlotte M. Niemeyer
Miriam Erlacher
Bruce R. Blazar
Burkard Becher
Olaf Groß
Tilman Brummer
Robert Zeiser
author_sort Shaima’a Hamarsheh
title Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation
title_short Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation
title_full Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation
title_fullStr Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation
title_full_unstemmed Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation
title_sort oncogenic krasg12d causes myeloproliferation via nlrp3 inflammasome activation
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/8d60e15645a540748f0978aece6a6bc5
work_keys_str_mv AT shaimaahamarsheh oncogenickrasg12dcausesmyeloproliferationvianlrp3inflammasomeactivation
AT lenaosswald oncogenickrasg12dcausesmyeloproliferationvianlrp3inflammasomeactivation
AT benediktssaller oncogenickrasg12dcausesmyeloproliferationvianlrp3inflammasomeactivation
AT susanneunger oncogenickrasg12dcausesmyeloproliferationvianlrp3inflammasomeactivation
AT donatelladefeo oncogenickrasg12dcausesmyeloproliferationvianlrp3inflammasomeactivation
AT janakimanojavinnakota oncogenickrasg12dcausesmyeloproliferationvianlrp3inflammasomeactivation
AT martinakonantz oncogenickrasg12dcausesmyeloproliferationvianlrp3inflammasomeactivation
AT franziskamuhl oncogenickrasg12dcausesmyeloproliferationvianlrp3inflammasomeactivation
AT heikobecker oncogenickrasg12dcausesmyeloproliferationvianlrp3inflammasomeactivation
AT michaellubbert oncogenickrasg12dcausesmyeloproliferationvianlrp3inflammasomeactivation
AT khalidshoumariyeh oncogenickrasg12dcausesmyeloproliferationvianlrp3inflammasomeactivation
AT christophschurch oncogenickrasg12dcausesmyeloproliferationvianlrp3inflammasomeactivation
AT geoffroyandrieux oncogenickrasg12dcausesmyeloproliferationvianlrp3inflammasomeactivation
AT nilsvenhoff oncogenickrasg12dcausesmyeloproliferationvianlrp3inflammasomeactivation
AT annetteschmittgraeff oncogenickrasg12dcausesmyeloproliferationvianlrp3inflammasomeactivation
AT sandraduquesne oncogenickrasg12dcausesmyeloproliferationvianlrp3inflammasomeactivation
AT dietmarpfeifer oncogenickrasg12dcausesmyeloproliferationvianlrp3inflammasomeactivation
AT matthewacooper oncogenickrasg12dcausesmyeloproliferationvianlrp3inflammasomeactivation
AT claudialengerke oncogenickrasg12dcausesmyeloproliferationvianlrp3inflammasomeactivation
AT melanieboerries oncogenickrasg12dcausesmyeloproliferationvianlrp3inflammasomeactivation
AT justusduyster oncogenickrasg12dcausesmyeloproliferationvianlrp3inflammasomeactivation
AT charlottemniemeyer oncogenickrasg12dcausesmyeloproliferationvianlrp3inflammasomeactivation
AT miriamerlacher oncogenickrasg12dcausesmyeloproliferationvianlrp3inflammasomeactivation
AT brucerblazar oncogenickrasg12dcausesmyeloproliferationvianlrp3inflammasomeactivation
AT burkardbecher oncogenickrasg12dcausesmyeloproliferationvianlrp3inflammasomeactivation
AT olafgroß oncogenickrasg12dcausesmyeloproliferationvianlrp3inflammasomeactivation
AT tilmanbrummer oncogenickrasg12dcausesmyeloproliferationvianlrp3inflammasomeactivation
AT robertzeiser oncogenickrasg12dcausesmyeloproliferationvianlrp3inflammasomeactivation
_version_ 1718386245033263104